Clinical Trial Update: Study of ExoFlo for the Treatment of Perianal Fistulas [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 clinical trial of ExoFlo for treating perianal fistulas, including Crohn's disease patients, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Perianal Fistula

Drugs mentioned

• ExoFlo

Snippet

Sponsor: Direct Biologics, LLC | Conditions: Perianal Fistula, Crohn's Disease | Phase 1, Phase 2 | Status: TERMINATED